Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of bacteremia and is associated with significant morbidity and mortality. Prior studies evaluating the association of vancomycin MICs with clinical outcomes in patients with MRSA bacteremia have been inconsistent. This study evalu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Adani, Shaili, Bhowmick, Tanaya, Weinstein, Melvin P., Narayanan, Navaneeth
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913979/
https://ncbi.nlm.nih.gov/pubmed/29378704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02512-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires